Physician
Texas Arthritis Center, PA
Texas Arthritis Center, PA was paid $2.53M by Medicaid between Sep 2019 and Dec 2024, across 13 billing codes. Its largest line is J0490, Injection, belimumab, 10 mg — 47% of everything it billed.
33Billing provider infoTEXAS ARTHRITIS CENTER, PA
EL PASO, TX 79902
EL PASO, TX 79902
33aNPI1548742349assigned 08/29/2018
33bProvider typeRheumatology Physician
28Total paid$2.53M
24GClaims16,373
24DCodes billed13
24AFirst – last monthSep 2019 – Dec 2024
Compared with peers
Next to other Rheumatology Physician providers in Texas
Rank by total paid#1 of 45
Median peer was paid$12K
This provider vs. median215×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 39 | $3K | |
| 2020 | 833 | $64K | |
| 2021 | 2,624 | $306K | |
| 2022 | 4,808 | $607K | |
| 2023 | 5,121 | $1.03M | |
| 2024incomplete | 2,948 | $517K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0490 | Injection, belimumab, 10 mg | 47% | 598 | 381 | $1.20M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 9,353 | 9,026 | $770K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.2% | 1,668 | 1,617 | $183K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.5% | 1,422 | 1,380 | $163K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5.6% | 1,585 | 1,407 | $142K |
| 99205 | Prolong outpt/office vis | 1.1% | 211 | 203 | $28K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | <1% | 15 | 12 | $22K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 229 | 223 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 817 | 767 | $11K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 355 | 318 | $2K |
| 96401 | <1% | 16 | 13 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 91 | 87 | $148.53 |
1 more codes
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 13 | $38.61 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHABRA, SANJAY (PRESIDENT)